Projects per year
Personal profile
Area of Expertise
The main focus of my research is to discover and develop bioactive natural products from microorganisms as drugs or drug leads for the treatment of cancer, infectious diseases, or other human medical conditions. In addition, I recently initiated a collaborative project for the engineering of novel oncolytic virus for cancer chemoimmunotherapy.
Key words: anti-aging, anti-cancer, anti-infective, crowd-sourcing, crowd-funding, drug discovery, drug development, natural product, synthetic biology, chemoimmunotherapy, contract service
Key words: anti-aging, anti-cancer, anti-infective, crowd-sourcing, crowd-funding, drug discovery, drug development, natural product, synthetic biology, chemoimmunotherapy, contract service
Education/Academic qualification
BS in Microbiology, Huazhong Agricultural University
MS in Phytochemistry, Institute of Botany of the Chinese Academy of Sciences
PhD in Botany & Microbiology, Michigan State University
Fingerprint
Dive into the research topics where Yiqiang (Eric) Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 5 Finished
-
High-Resolution Tandem Mass Spectrometer for Advanced Biomolecular Research
Prokai, L., Forster, M. & Cheng, Y. (.
27/01/17 → 31/01/18
Project: Research
-
Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents
NCI: National Cancer Institute
1/06/13 → 31/05/15
Project: Research
-
Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents
Cheng, Y. (., Cheng, Y. (., CHENG, Y. & CHENG, Y.
1/08/10 → 30/11/15
Project: Research
-
Antibiotics Discovery from the Great Lakes
Cheng, Y. (. & CHENG, Y.
1/07/07 → 30/06/10
Project: Research
Research Output
-
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment
Guenter, R., Aweda, T., Carmona Matos, D. M., Jang, S., Whitt, J., Cheng, Y. Q., Liu, X. M., Chen, H., Lapi, S. E. & Jaskula-Sztul, R., Jan 2020, In: Surgery (United States). 167, 1, p. 189-196 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Origin and bioactivities of thiosulfinated FK228
Liu, X., Currens, G. C., Xue, L. & Cheng, Y. Q., 2019, In: MedChemComm. 10, 4, p. 538-542 5 p.Research output: Contribution to journal › Article › peer-review
-
Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors
Guenter, R. E., Aweda, T., Matos, D. M. C., Whitt, J., Chang, A. W., Cheng, E. Y., Liu, X. M., Chen, H., Lapi, S. E. & Jaskula-Sztul, R., Jun 2019, In: Cancers. 11, 6, 767.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
The ADEP biosynthetic gene cluster in Streptomyces hawaiiensis NRRL 15010 reveals an accessory clpP gene as a novel antibiotic resistance factor
Thomy, D., Culp, E., Adamek, M., Cheng, E. Y., Ziemert, N., Wright, G. D., Sass, P. & Brötz-Oesterhelt, H., 2019, In: Applied and Environmental Microbiology. 85, 20, e01292-19.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin
Saraiva, R. G., Huitt-Roehl, C. R., Tripathi, A., Cheng, Y. Q., Bosch, J., Townsend, C. A. & Dimopoulos, G., 1 Dec 2018, In: Scientific Reports. 8, 1, 6176.Research output: Contribution to journal › Article › peer-review
15 Scopus citations